More than 250 executives said that the decision ignored both scientific and legal precedent and, if it stands, would create uncertainty for the pharmaceutical and biotech industries.
Author: Christina Jewett
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}